Javier P. Gisbert, José María Pajares, Istvan Racz

Research output: Contribution to journalArticle

11 Citations (Scopus)


During the past year omeprazole-based triple therapies have achieved relatively low eradication rates, which lends support to the assertion that new regimens need to be developed. Other proton pump inhibitors (lansoprazole, pantoprazole, rabeprazole and esomeprazole) and ranitidine bismuth citrate have achieved results that are comparable to those of omeprazole. The optimal duration of eradication treatment (7-14 days) remains controversial. Second-line regimens, for use when eradication treatment with first-line regimens fails, have achieved high cumulative eradication rates. There is still a need for new compounds that are specific for Helicobacter pylori.

Original languageEnglish
Pages (from-to)S47-S54
JournalCurrent Opinion in Gastroenterology
Issue numberSUPPL. 1
Publication statusPublished - Dec 1 2001


ASJC Scopus subject areas

  • Gastroenterology

Cite this

Gisbert, J. P., Pajares, J. M., & Racz, I. (2001). Therapy. Current Opinion in Gastroenterology, 17(SUPPL. 1), S47-S54.